IT8148925A0 - Formulazione farmaceutica per uso locale adatta al trattamento di in fezioni della pelle e delle mucose - Google Patents

Formulazione farmaceutica per uso locale adatta al trattamento di in fezioni della pelle e delle mucose

Info

Publication number
IT8148925A0
IT8148925A0 IT8148925A IT4892581A IT8148925A0 IT 8148925 A0 IT8148925 A0 IT 8148925A0 IT 8148925 A IT8148925 A IT 8148925A IT 4892581 A IT4892581 A IT 4892581A IT 8148925 A0 IT8148925 A0 IT 8148925A0
Authority
IT
Italy
Prior art keywords
mucosaus
infections
skin
treatment
pharmaceutical formulation
Prior art date
Application number
IT8148925A
Other languages
English (en)
Other versions
IT1171399B (it
Inventor
Trevor Mervyn Jones
Alan Robert White
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26276273&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IT8148925(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of IT8148925A0 publication Critical patent/IT8148925A0/it
Application granted granted Critical
Publication of IT1171399B publication Critical patent/IT1171399B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT48925/81A 1980-07-18 1981-07-17 Formulazione farmaceutica per uso locale adatta al trattamento di infezioni della pelle e delle mucose IT1171399B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8023645 1980-07-18
GB8033218A GB2080106B (en) 1980-07-18 1980-10-15 Acyclovin preparations

Publications (2)

Publication Number Publication Date
IT8148925A0 true IT8148925A0 (it) 1981-07-17
IT1171399B IT1171399B (it) 1987-06-10

Family

ID=26276273

Family Applications (1)

Application Number Title Priority Date Filing Date
IT48925/81A IT1171399B (it) 1980-07-18 1981-07-17 Formulazione farmaceutica per uso locale adatta al trattamento di infezioni della pelle e delle mucose

Country Status (30)

Country Link
EP (1) EP0044543B1 (it)
AR (1) AR225680A1 (it)
AT (1) AT381025B (it)
AU (1) AU547391B2 (it)
BG (1) BG60450B2 (it)
CA (1) CA1172169A (it)
CS (1) CS229674B2 (it)
CY (1) CY1309A (it)
DD (1) DD203464A5 (it)
DE (1) DE3163982D1 (it)
DK (1) DK149191C (it)
ES (1) ES504046A0 (it)
FI (1) FI76255C (it)
GB (1) GB2080106B (it)
GR (1) GR75104B (it)
HK (1) HK95485A (it)
HU (1) HU185936B (it)
IE (1) IE51120B1 (it)
IL (1) IL63351A (it)
IT (1) IT1171399B (it)
MC (1) MC1408A1 (it)
MY (1) MY8600389A (it)
NO (1) NO155038C (it)
NZ (1) NZ197744A (it)
PH (1) PH16308A (it)
PL (1) PL135416B1 (it)
PT (1) PT73391B (it)
RO (1) RO82678A (it)
SG (1) SG72085G (it)
ZW (1) ZW17181A1 (it)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0095813A3 (en) * 1982-06-01 1985-05-08 THE PROCTER & GAMBLE COMPANY Penetrating topical pharmaceutical compositions containing 9-(2-hydroxyethoxymethyl) guanine
US4557934A (en) 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
GB8602346D0 (en) * 1986-01-30 1986-03-05 Wellcome Found Antiviral combinations
GB8917959D0 (en) * 1989-08-05 1989-09-20 Beecham Group Plc Pharmaceutical formulation
US6469015B1 (en) 1990-01-26 2002-10-22 Novartis International Pharmaceutical Ltd Pharmaceutical formulation
GB9001886D0 (en) * 1990-01-26 1990-03-28 Beecham Group Plc Pharmaceutical formulation
ATE158222T1 (de) * 1992-03-20 1997-10-15 Unichema Chemie Bv Formtrennzusammensetzung
DK169121B1 (da) * 1992-09-09 1994-08-22 Gea Farmaceutisk Fabrik As Antiviralt virksom farmaceutisk olie-i-vand-emulsion indeholdende 9-[(2-hydroxyethoxy)methyl]guanin (acyclovir) eller et salt eller en ester deraf
DE4416674C2 (de) * 1994-05-11 1997-01-30 Rentschler Arzneimittel Topische Zubereitung enthaltend Aciclovir
DE19517147C2 (de) * 1995-05-10 1999-07-01 Hexal Pharmaforschung Gmbh Aciclovir-Zubereitung
AU2036297A (en) * 1996-03-20 1997-10-10 Glaxo Group Limited Topical formulations of aciclovir
GB9611167D0 (en) * 1996-05-29 1996-07-31 Glaxo Group Ltd Medicaments
GB9718568D0 (en) 1997-09-03 1997-11-05 Chauvin Pharmaceuticals Limite Compositions
GB9718791D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Medicaments
ITMI981528A1 (it) * 1998-07-03 2000-01-03 Recordati Ind Chimica E Farma Formulazioni topiche di aciclovir
US7223387B2 (en) 1998-11-18 2007-05-29 Medivir Ab Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
GB9828620D0 (en) * 1998-12-23 1999-02-17 Glaxo Group Ltd Medicaments
FR2837102B1 (fr) * 2002-03-18 2004-10-08 Palbian Snc Composition a l'etat de gel aqueux, procede de fabrication et utilisation pour la fabrication d'un medicament, notamment antiherpetique
ATE396732T1 (de) * 2004-04-05 2008-06-15 Liomont S A De C V Lab Neue antivirale pharmazeutische zusammensetzung
EP2005824A1 (de) † 2007-06-21 2008-12-24 Bayer CropScience AG Wirkstoffsuspensionen in Glycerin
WO2017029298A1 (en) 2015-08-17 2017-02-23 Sanovel Ilac Sanayi Ve Ticaret A.S. A topical antiviral composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3892857A (en) * 1972-11-24 1975-07-01 Squibb & Sons Inc Steroid formulation
ZA738657B (en) * 1973-01-05 1974-10-30 Hoffmann La Roche Emulsions
GB1478009A (en) * 1973-04-02 1977-06-29 Glaxo Lab Ltd Pharmaceutical compositions
US4199574A (en) * 1974-09-02 1980-04-22 Burroughs Wellcome Co. Methods and compositions for treating viral infections and guanine acyclic nucleosides
GB1543907A (en) * 1975-02-19 1979-04-11 Dermal Labor Ltd Steroid compositions
US3934013A (en) * 1975-02-21 1976-01-20 Syntex (U.S.A.) Inc. Pharmaceutical composition
US4049802A (en) * 1975-03-19 1977-09-20 Research Corporation Zinc sulfadiazine and its use in the treatment of burns
GB1554720A (en) * 1975-07-10 1979-10-24 Nyegaard & Co As Pyridthione derivatives
US4141976A (en) * 1976-01-05 1979-02-27 The Regents Of The University Of Michigan Process for alleviating proliferative skin diseases
DE2847975A1 (de) * 1978-11-04 1980-05-14 Merck Patent Gmbh Verfahren zur bindung von freiem formaldehyd in pharmazeutischen und kosmetischen zubereitungen

Also Published As

Publication number Publication date
PT73391B (en) 1983-06-15
FI76255C (fi) 1990-03-14
PL135416B1 (en) 1985-10-31
FI76255B (fi) 1988-06-30
GB2080106A (en) 1982-02-03
ATA318081A (de) 1986-01-15
IL63351A0 (en) 1981-10-30
FI812257L (fi) 1982-01-19
AU547391B2 (en) 1985-10-17
CS229674B2 (en) 1984-06-18
DE3163982D1 (en) 1984-07-12
NZ197744A (en) 1983-05-10
IE51120B1 (en) 1986-10-01
DK149191B (da) 1986-03-10
BG60450B2 (bg) 1995-04-28
AT381025B (de) 1986-08-11
CY1309A (en) 1985-12-06
HU185936B (en) 1985-04-28
DK321681A (da) 1982-01-19
ES8305363A1 (es) 1983-04-01
EP0044543A1 (en) 1982-01-27
ZW17181A1 (en) 1983-02-23
ES504046A0 (es) 1983-04-01
PT73391A (en) 1981-08-01
EP0044543B1 (en) 1984-06-06
GB2080106B (en) 1984-03-07
MC1408A1 (fr) 1982-07-16
SG72085G (en) 1986-05-02
NO812464L (no) 1982-01-19
NO155038C (no) 1987-02-04
AR225680A1 (es) 1982-04-15
CA1172169A (en) 1984-08-07
IL63351A (en) 1983-10-31
NO155038B (no) 1986-10-27
PL232259A1 (en) 1983-07-04
AU7307381A (en) 1982-01-21
DD203464A5 (de) 1983-10-26
IT1171399B (it) 1987-06-10
DK149191C (da) 1986-09-08
MY8600389A (en) 1986-12-31
PH16308A (en) 1983-09-05
RO82678A (ro) 1984-05-23
HK95485A (en) 1985-12-06
IE811617L (en) 1982-01-18
GR75104B (it) 1984-07-13

Similar Documents

Publication Publication Date Title
IT8148925A0 (it) Formulazione farmaceutica per uso locale adatta al trattamento di in fezioni della pelle e delle mucose
IT8248898A0 (it) Metodo per la preparazione di derivati gangliosidici e loro uso in preparazioni farmaceutiche
IT1147806B (it) Complessi di ciclodestrine e glicosidi cardiaci per uso terapeutico e procedimento di preparazione
IT7948177A0 (it) Procedimento ed apparecchio per rivelare la posizione di corpi capaci di riflettere radiazioni
IT1218836B (it) Composizione cosmetica contenente derivati idrossilati di calcone e suo impiego per la protezione della pelle e dei capelli contro le radiazioni di luce derivati di calcone e procedimento per la loro preparazione
IT1107976B (it) Strumento e procedimento per la erogazione di fluidi in particolare per uso medicale
IT1153294B (it) Composizione di antralina migliorata e suo uso nel trattamento di malattie della pelle
IT1193627B (it) Composizione di antralina oppure di uno dei suoi derivati in un estere aromatico e suo impiego nel trattamento di matlattie della pelle e delle unghie
IT1217121B (it) Eteri di poligliceroli e loro impiego in composizioni cosmetiche e farmaceutiche
IT8921650A0 (it) Composizioni ad uso topico contenenti acidi nucleici depolimerizzati per la cosmesi della pelle e del corpo.
ES2023286B3 (es) Composicion cosmetica o farmaceutica de uso cutaneo y procedimiento para la preparacion de tal composicion
IT1119853B (it) Composizione farmaceutica comprendente l-carnitina per il trattamento delle dislipidemie ed iperlipo proteinemie
IT8012639A0 (it) Dispositivo per il trattamento di frutta ed infruttescenze in particolare per il trattamento di melagra ne e o granadiglie
IT1104828B (it) Procedimento e dispositivo per la depurazione di sostanze solide in particolare di silicio
IT8709430A0 (it) Utilizzazione di forme farmaceutiche per uso topico contenenti miocamicina per la terapia delle infezioni da germi sensibili alla miocamicina stessa
IT1110530B (it) Dispositivo di soccorso ad uso di naufraghi o infortunati
IT1170862B (it) Mercaptoacil-carnitine procedimento per la loro preparazione e loro uso terapeutico
IT8067516A0 (it) Apparecchio di idroterapia in particolare per il trattamento delle algie vertebrali
IT8167784A0 (it) Agente antinfiammatorio per uso esterno in uomini ed animali
IT8619457A1 (it) Derivati insaturi cicloalifatici, loro procedimenti di preparazione e loro impiego in terapia e in cosmetica
ITRM920351A1 (it) Formulazione farmaceutica per uso topico, indicata nel trattamento di infezioni virali della pelle e delle mucose.
IT1219568B (it) Uso di enalapril nel trattamento terapeutico delle cefalee essenziali
IT1171692B (it) Preparato farmaceutico impiegabile per il trattamento della lebbra e/o di altre micobatteriosi
IT1167939B (it) Uso di derivati mercaptoacil-sostituiti della prolina nella terapia delle cefalee essenziali
IT1058036B (it) Procedimento per la preparazione di soluzioni basiche contenenti alluminio in particolare per il trattamento di acque

Legal Events

Date Code Title Description
ITCP Complementary protection certificate

Free format text: CCP 199

MEDD Supplementary protection certificate for pharmaceutical products: granted

Free format text: CCP 199, 19920429; THE WELLCOME FOUNDATION LIMITED

TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970730